KOSPI Composite Index Rises 0.83% This Week to 2558.81 — Data Talk
The KOSPI Composite Index is up 21.02 points or 0.83% this week to 2558.81
--Up for two consecutive weeks
--Up 83.39 points or 3.37% over the last two weeks
--Largest two-week point and percentage gain since the week ending April 14, 2023
--Today it is up 4.12 points or 0.16%
--Snaps a two-trading-day losing streak
--Up eight of the past 10 trading days
--Off 22.58% from its record close of 3305.21 hit Tuesday, July 6, 2021
--Off 4.73% from its 52-week high of 2685.90 hit Tuesday, May 31, 2022
--Up 18.71% from its 52-week low of 2155.49 hit Friday, Sept. 30, 2022
--Down 3.00% from 52 weeks ago
--Off 0.66% from its 2023 closing high of 2575.91 hit Monday, April 17, 2023
--Up 15.33% from its 2023 closing low of 2218.68 hit Tuesday, Jan. 3, 2023
--Month-to-date it is up 2.29%
--Year-to-date it is up 322.41 points or 14.42%
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 26, 2023 06:47 ET (10:47 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
After Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?
-
Is ServiceNow Stock a Buy After Earnings and Its Investor Day?
-
3 Stocks to Buy and 3 Stocks to Sell After Earnings
-
Markets Brief: Is It Really a Surprising Quarter for Earnings?
-
After Earnings, Is Berkshire Hathaway Stock a Buy, a Sell, or Fairly Valued?
-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Occidental Earnings: CrownRock Transaction Should Still Close, but Not Until the Third Quarter
-
After Earnings, Is Apple Stock a Buy, a Sell, or Fairly Valued?
-
Uber Earnings: Network Effect Continues to Drive Profitable Growth for Uber
-
Undervalued by 28%, This Stock Is a Buy for Patient Investors
-
10 Best Growth Stocks to Buy for the Long Term
-
The Best Technology Stocks to Buy
-
After Earnings, Is Coke Stock a Buy, a Sell, or Fairly Valued?
-
Disney Earnings: Improved Streaming Results Come at the Expense of Continued Linear Weakness